The CRISPR community is facing a tsunami of data but a dearth of computational tools required for their analyses. By empowering the researcher, Latch is helping remove a significant bottleneck that is currently slowing down the CRISPR research cycle, enabling the discovery of new therapies.
Investors 2
Date | Name | Website |
07.10.2021 | Lux Capita... | luxcapital... |
- | Axial VC | axialvc.co... |
Mentions in press and media 1
Date | Title | Description |
- | Biocomputing Data Infrastructure Company Latch Bio Raises $5 Million | Latch Bio — a company building data infrastructure for the biocomputing revolution — announced the closing of a $5 million seed funding round. These are the details. Latch Bio — a company building data infrastructure for the biocomputing re... |